RAPT Therapeutics, Inc.
RAPT
$11.32
$0.5955.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 28.88M | 28.37M | 28.88M | 27.33M | 27.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 113.05M | 122.85M | 136.10M | 114.85M | 128.98M |
| Operating Income | -113.05M | -122.85M | -136.10M | -114.85M | -128.98M |
| Income Before Tax | -106.49M | -116.51M | -129.87M | -107.49M | -120.43M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -106.49 | -116.51 | -129.87 | -107.49 | -120.43 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -106.49M | -116.51M | -129.87M | -107.49M | -120.43M |
| EBIT | -113.05M | -122.85M | -136.10M | -114.85M | -128.98M |
| EBITDA | -111.99M | -121.71M | -134.90M | -113.61M | -127.72M |
| EPS Basic | -14.21 | -19.25 | -24.93 | -22.24 | -24.99 |
| Normalized Basic EPS | -8.95 | -12.10 | -15.77 | -14.19 | -15.91 |
| EPS Diluted | -14.21 | -19.25 | -24.93 | -22.24 | -24.99 |
| Normalized Diluted EPS | -8.95 | -12.10 | -15.77 | -14.19 | -15.91 |
| Average Basic Shares Outstanding | 64.57M | 42.48M | 20.39M | 19.35M | 19.28M |
| Average Diluted Shares Outstanding | 64.57M | 42.48M | 20.39M | 19.35M | 19.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |